Trade Summary

3 months ago, Feinberg Peter, serving as Dir at Immuneering Corp (IMRX), purchased 7,500 shares at $7.03 per share, for a total transaction value of $52,730.00. Following this transaction, Feinberg Peter now holds 1,133,564 shares of IMRX.

This purchase represents a 1.00% increase in Feinberg Peter's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, September 30, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, October 1, 2025, 1 day after the trade was made.

Immuneering Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.